Erythrocyte morphology in metabolic syndrome

Expert Review of Hematology

Volumn 5, Issue 5, 2012, Pages 523-531

  Gyawali, Prajwal ^a   Richards, Ross S ^a   Uba Nwose, Ezekiel ^b  

^a CHARLES STURT UNIVERSITY   (Australia)

^b CHARLES DARWIN UNIVERSITY   (Australia)

Author keywords

diabetes mellitus; erythrocyte morphology; hemorheology; hypertension; metabolic syndrome; oxidative stress

Indexed keywords

ATOMIC FORCE MICROSCOPY; BLOOD RHEOLOGY; CHRONIC DISEASE; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DYSLIPIDEMIA; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE STRUCTURE; HUMAN; HYPERTENSION; METABOLIC SYNDROME X; NOMENCLATURE; OBESITY; OXIDATIVE STRESS; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; REVIEW; SCANNING ELECTRON MICROSCOPY;

DIABETES MELLITUS; DYSLIPIDEMIAS; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTES; HUMANS; HYPERTENSION; METABOLIC SYNDROME X; OBESITY; OXIDATIVE STRESS;

EID: 84869189805     PISSN: 17474086     EISSN: 17474094     Source Type: Journal    
DOI: 10.1586/ehm.12.47     Document Type: Review

References (73)

1. Dintenfass L. Blood Microrheology: Viscosity Factors in Blood Flow, Ischaemia, and Thrombosis. Butterworth, London, UK (1971).
2. Deuticke B. Transformation and restoration of biconcave shape of human erythrocytes induced by amphiphilic agents and changes of ionic environment. Biochim. Biophys. Acta 163(4), 494-500 (1968).
3. Sheetz MP, Singer SJ. Biological membranes as bilayer couples. A molecular mechanism of drug-erythrocyte interactions. Proc. Natl Acad. Sci. USA 71(11), 4457-4461 (1974).
4. Chabanel A, Reinhart W, Chien S. Increased resistance to membrane deformation of shape-transformed human red blood cells. Blood 69(3), 739-743 (1987).
5. Reinhart WH, Chien S. Red cell rheology in stomatocyte-echinocyte transformation: roles of cell geometry and cell shape. Blood 67(4), 1110-1118 (1986).
6. Richards RS, Nwose EU. Blood viscosity at different stages of diabetes pathogenesis. Br. J. Biomed. Sci. 67(2), 67-70 (2010).
7. Madsen JW, Nagel RL, Rybicki AC, Schwartz RS. Oxidation of spectrin and deformability defects in diabetic erythrocytes. Diabetes 40(6), 701-708 (1991).
8. Derganc J, Bozic B, Svetina S, Zeks B. Equilibrium shapes of erythrocytes in rouleau formation. Biophys. J. 84(3), 1486-1492 (2003).
9. Chien S. Shear dependence of effective cell volume as a determinant of blood viscosity. Science 168(3934), 977-979 (1970).
10. Schmid-Schönbein H, Wells R, Goldstone J. Influence of deformability of human red cells upon blood viscosity. Circ. Res. 25(2), 131-143 (1969).
11. Williamson JR, Gardner RA, Boylan CW et al. Microrheologic investigation of erythrocyte deformability in diabetes mellitus. Blood 65(2), 283-288 (1985).
12. Diamantopoulos EJ, Raptis SA, Moulopoulos SD. Red blood cell deformability index in diabetic retinopathy. Horm. Metab. Res. 19(11), 569-573 (1987).
13. Brown CD, Ghali HS, Zhao Z, Thomas LL, Friedman EA. Association of reduced red blood cell deformability and diabetic nephropathy. Kidney Int. 67(1), 295-300 (2005).
14. Kahn R, Buse J, Ferrannini E, Stern M; American Diabetes Association; European Association for the Study of Diabetes. The metabolic syndrome: Time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28(9), 2289-2304 (2005).
15. Expert Panel on Detection Evaluation Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285(19), 2486-2497 (2001).
16. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 40(4), 405-412 (1991).
17. Turchetti V, De Matteis C, Leoncini F, Trabalzini L, Guerrini M, Forconi S. Variations of erythrocyte morphology in different pathologies. Clin. Hemorheol. Microcirc. 17(3), 209-215 (1997).
18. Turchetti V, Leoncini F, De Matteis C, Trabalzini L, Guerrini M, Forconi S. Evaluation of erythrocyte morphology as deformability index in patients suffering from vascular diseases, with or without diabetes mellitus: correlation with blood viscosity and intra-erythrocytic calcium. Clin. Hemorheol. Microcirc. 18(2-3), 141-149 (1998).
19. Cimbaljević B, Vasilijević A, Cimbaljević S et al. Inter-relationship of antioxidative status, lipid peroxidation, and lipid profile in insulin-dependent and non-insulindependent diabetic patients. Can. J. Physiol. Pharmacol. 85(10), 997-1003 (2007).
20. Starodubtseva MN, Kuznetsova TG, Yegorenkov NI, Cherenkevich SN. Structural and mechanical characteristics of erythrocyte membranes in patients with Type 2 diabetes mellitus. Bull. Exp. Biol. Med. 145(1), 99-103 (2008).
21. Wautier JL, Paton RC, Wautier MP et al. Increased adhesion of erythrocytes to endothelial cells in diabetes mellitus and its relation to vascular complications. N. Engl. J. Med. 305(5), 237-242 (1981).
22. Babu N, Singh M. Influence of hyperglycemia on aggregation, deformability and shape parameters of erythrocytes. Clin. Hemorheol. Microcirc. 31(4), 273-280 (2004).
23. Straface E, Rivabene R, Masella R, Santulli M, Paganelli R, Malorni W. Structural changes of the erythrocyte as a marker of non-insulin-dependent diabetes: protective effects of N-acetylcysteine. Biochem. Biophys. Res. Commun. 290(5), 1393-1398 (2002).
24. Postnov YV, Orlov SN, Shevchenko A, Adler AM. Altered sodium permeability, calcium binding and Na-K-ATPase activity in the red blood cell membrane in essential hypertension. Pflugers Arch. 371(3), 263-269 (1977).
25. Postnov YV. An approach to the explanation of cell membrane alteration in primary hypertension. Hypertension 15(3), 332-337 (1990).
26. Cicco G, Pirrelli A. Red blood cell (RBC) deformability, RBC aggregability and tissue oxygenation in hypertension. Clin. Hemorheol. Microcirc. 21(3-4), 169-177 (1999).
27. Tripsa MF, Zaciu A. Erythrocyte molecular shape modifications in the primary hypertension. Rev. Roum. Physiol. 27(3-4), 155-159 (1990).
28. Teodori L, Accorsi A, Uguccioni F et al. Erythrocyte morphology automated analysis: proposal for a new prediction tool of essential hypertension diagnosis. Cytometry B. Clin. Cytom. 72(3), 211-214 (2007).
29. Turchetti V, Bellini MA, Guerrini M, Forconi S. Evaluation of hemorheological parameters and red cell morphology in hypertension. Clin. Hemorheol. Microcirc. 21(3-4), 285-289 (1999).
30. Zipursky A, Brown E, Palko J, Brown EJ. The erythrocyte differential count in newborn infants. Am. J. Pediatr. Hematol. Oncol. 5(1), 45-51 (1983).
31. Postnov YV, Kravtsov GM, Orlov SN et al. Regulation by protein kinase C of erythrocyte shape, volume and passive sodium permeability: Alteration in essential hypertension. J. Hypertens. 5, s257-s259 (1987).
32. Postnov YV, Kravtsov GM, Orlov SN, Pokudin NI, Postnov IY, Kotelevtsev YV. Effect of protein kinase C activation on cytoskeleton and cation transport in human erythrocytes. Reproduction of some membrane abnormalities revealed in essential hypertension. Hypertension 12(3), 267-273 (1988).
33. Babu N. Influence of cholesterol on shape parameters of erythrocytes in hyperglycemic subjects. Turk. J. Hematol. 26(2), 77-81 (2009).
34. Babu N. Influence of hypercholesterolemia on deformability and shape parameters of erythrocytes in hyperglycemic subjects. Clin. Hemorheol. Microcirc. 41(3), 169-177 (2009).
35. Józwiak Z, Palecz D, Bartosz G. The interactions of modified lipoproteins with human erythrocyte membranes. Biochem. Mol. Biol. Int. 32(2), 259-267 (1994).
36. Kanakaraj P, Singh M. Influence of cholesterol-enrichment under in vivo and in vitro conditions on the erythrocyte membrane lipids and its deformability. Indian J. Biochem. Biophys. 26(6), 381-385 (1989).
37. Siegel I, Liu TL, Zaret P, Gleicher N. Parenteral fat emulsions and immune adherence. The effects of triglycerides on red cell and neutrophil immune adherence in vitro and in vivo. JAMA 251(12), 1574-1579 (1984).
38. Zhao T, Guo J, Li H et al. Hemorheological abnormalities in lipoprotein lipase deficient mice with severe hypertriglyceridemia. Biochem. Biophys. Res. Commun. 341(4), 1066-1071 (2006).
39. Matsuzawa Y, Funahashi T, Nakamura T. Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann. NY Acad. Sci. 892, 146-154 (1999).
40. Satoh N, Kotani K, Wada H et al. Unfavorable blood rheology is closely associated with arterial stiffness in obese patients. Endocr. J. 56(7), 915-918 (2009).
41. Vayá A, Hernández-Mijares A, Suescun M et al. Metabolic alterations in morbid obesity. Influence on the haemorheological profile. Clin. Hemorheol. Microcirc. 48(4), 247-255 (2011).
42. Furukawa S, Fujita T, Shimabukuro M et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 114(12), 1752-1761 (2004).
43. Zavodnik IB, Zaborowski A, Niekurzak A, Bryszewska M. Effect of free fatty acids on erythrocyte morphology and membrane fluidity. Biochem. Mol. Biol. Int. 42(1), 123-133 (1997).
44. Mehlhorn RJ. Ascorbate- and dehydroascorbic acid-mediated reduction of free radicals in the human erythrocyte. J. Biol. Chem. 266(5), 2724-2731 (1991).
45. Toth KM, Clifford DP, Berger EM, White CW, Repine JE. Intact human erythrocytes prevent hydrogen peroxide-mediated damage to isolated perfused rat lungs and cultured bovine pulmonary artery endothelial cells. J. Clin. Invest. 74(1), 292-295 (1984).
46. Richards RS, Roberts TK, Dunstan RH, McGregor NR, Butt HL. Erythrocyte antioxidant systems protect cultured endothelial cells against oxidant damage. Biochem. Mol. Biol. Int. 46(5), 857-865 (1998).
47. Richards RS, Roberts TK, Mathers D, Dunstan RH, Butt HL. Erythrocytes protect cultured endothelial cells from neutrophil-mediated damage. Aust. J. Med. Sci. 18, 73-77 (1997).
48. Snyder LM, Fortier NL, Trainor J et al. Effect of hydrogen peroxide exposure on normal human erythrocyte deformability, morphology, surface characteristics, and spectrin-hemoglobin cross-linking. J. Clin. Invest. 76(5), 1971-1977 (1985).
49. Babior BM, Kipnes RS, Curnutte JT. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J. Clin. Invest. 52(3), 741-744 (1973).
50. Zavodnik LB, Zavodnik IB, Niekurzak A, Szosland K, Bryszewska M. Activation of red blood cell glutathione peroxidase and morphological transformation of erythrocytes under the action of tert-butyl hydroperoxide. Biochem. Mol. Biol. Int. 44(3), 577-588 (1998).
51. Richards RS, Roberts TK, McGregor NR, Dunstan RH, Butt HL. The role of erythrocytes in the inactivation of free radicals. Med. Hypotheses 50(5), 363-367 (1998).
52. Watanabe H, Kobayashi A, Yamamoto T, Suzuki S, Hayashi H, Yamazaki N. Alterations of human erythrocyte membrane fluidity by oxygen-derived free radicals and calcium. Free Radic. Biol. Med. 8(6), 507-514 (1990).
53. Starodubtseva MN, Kuznetsova TG, Cherenkevich SN. Effect of peroxynitrite on mechanical properties of human erythrocyte membranes. Bull. Exp. Biol. Med. 143(2), 264-267 (2007).
54. Starodubtseva MN, Tattersall AL, Kuznetsova TG, Yegorenkov NI, Ellory JC. Structural and functional changes in the membrane and membrane skeleton of red blood cells induced by peroxynitrite. Bioelectrochemistry 73(2), 155-162 (2008).
55. Anichkov DA, Maksina AG, Shostak NA. Relationships between erythrocyte membrane properties and components of metabolic syndrome in women. Med. Sci. Monit. 11(4), CR203-CR210 (2005).
56. Vayá A, Hernández-Mijares A, Bonet E et al. Association between hemorheological alterations and metabolic syndrome. Clin. Hemorheol. Microcirc. 49(1-4), 493-503 (2011).
57. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414(6865), 813-820 (2001).
58. Nakhjavani M, Esteghamati A, Nowroozi S, Asgarani F, Rashidi A, Khalilzadeh O. Type 2 diabetes mellitus duration: An independent predictor of serum malondialdehyde levels. Singapore Med. J. 51(7), 582-585 (2010).
59. Shin CS, Moon BS, Park KS et al. Serum 8-hydroxy-guanine levels are increased in diabetic patients. Diabetes Care 24(4), 733-737 (2001).
60. Pácal L, Varvarovská J, Rušavý Z et al. Parameters of oxidative stress, DNA damage and DNA repair in Type 1 and Type 2 diabetes mellitus. Arch. Physiol. Biochem. 117(4), 222-230 (2011).
61. Pan HZ, Zhang L, Guo MY et al. The oxidative stress status in diabetes mellitus and diabetic nephropathy. Acta Diabetol. 47(Suppl. 1), 71-76 (2010).
62. Chiu D, Kuypers F, Lubin B. Lipid peroxidation in human red cells. Semin. Hematol. 26(4), 257-276 (1989).
63. Jain SK, Mohandas N, Clark MR, Shohet SB. The effect of malonyldialdehyde, a product of lipid peroxidation, on the deformability, dehydration and 51Crsurvival of erythrocytes. Br. J. Haematol. 53(2), 247-255 (1983).
64. Straface E, Gambardella L, Mattatelli A et al. The red blood cell as a genderassociated biomarker in metabolic syndrome: A pilot study. Int. J. Cell Biol. 2011, 204157 (2011).
65. Williams WJ, Beutler E, Erslev AJ, Rundles RW. Hematology. McGraw-Hill, Inc., NY, USA (1972).
66. Eriksson LE. On the shape of human red blood cells interacting with flat artificial surfaces - the 'glass effect'. Biochim. Biophys. Acta 1036(3), 193-201 (1990).
67. Mehta NG. Role of membrane integral proteins in the modulation of red cell shape by albumin, dinitrophenol and the glass effect. Biochim. Biophys. Acta 762(1), 9-18 (1983).
68. Baskurt OK, Boynard M, Cokelet GC et al.; International Expert Panel for Standardization of Hemorheological Methods. New guidelines for hemorheological laboratory techniques. Clin. Hemorheol. Microcirc. 42(2), 75-97 (2009).
69. Richards RS, Wang L, Jelinek H. Erythrocyte oxidative damage in chronic fatigue syndrome. Arch. Med. Res. 38(1), 94-98 (2007).
70. Bessis M. Red cell shapes. An illustrated classification and its rationale. Nouv. Rev. Fr. Hematol. 12(6), 721-745 (1972).
71. Shin S, Ku YH, Suh JS, Singh M. Rheological characteristics of erythrocytes incubated in glucose media. Clin. Hemorheol. Microcirc. 38(3), 153-161 (2008).
72. Candiloros H, Muller S, Zeghari N, Donner M, Drouin P, Ziegler O. Decreased erythrocyte membrane fluidity in poorly controlled IDDM. Influence of ketone bodies. Diabetes Care 18(4), 549-551 (1995).
73. Srour MA, Bilto YY, Juma M. Susceptibility of erythrocytes from non-insulin-dependent diabetes mellitus and hemodialysis patients, cigarette smokers and normal subjects to in vitro oxidative stress and loss of deformability. Clin. Hemorheol. Microcirc. 22(3), 173-180 (2000).